Login

Evli Fund Management Company Ltd. provides insights into the market outlook for infrastructure investments. 00:10:00

Share On Facebook Share On Twitter

Mikael Thunved is CEO:Evli AB at Evli Fund Management Co Ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Seed and seed stage firm investing in health, climate and empowerment|Adam Besvinick, Partner,Looking Glass Capital
00:10:00
Anthony Chukumba, managing director at Loop Capital, discusses GameStop's new CEO, who hails from Amazon, on 'Closing Bell'.
00:10:00
Kohl's Faces Dire Straits Amid Struggling Sales Process and Takeover Bids
00:10:00
Challenger Exploration: Advancing High-Grade Gold Projects in Argentina and Ecuador
00:10:00
CapMan's Business Model and Investment Appeal Explained by CEO Joakim Frimodig | Joakim Frimodig, CEO, CapMan.
00:10:00
Tailwind is focused on control investments in high quality, middle market companies|Caroline Adams,Vp,Tailwind Management LP
00:10:00
John McCluskey of Alamos Gold Discusses Gold's Highs, Scarcity, and Innovations in Mining
00:10:00
Celebrating Connections: Spreading Joy and Kindness|Jim McCann,Founder,1800Flowers
00:10:00
Fred Ernest Discusses Vista Gold's Mount Todd Project and Staged Development Strategy
00:10:00
Interview with Ray Marks, President and CEO of Handstone Gold Corporation: Exciting Drill Results in the Golden Triangle
00:10:00
Focuses on early-stage venture investing in mobile marketplaces social infrastructure and enterprise software|Chetan Puttaguntak,General Partner,Benchmark
00:10:00
Jonathan Thomas and Primerica Strategic Partner, American Century | Jonathan Thomas, CEO , American Century Investments.

© 2017 - Neuhu+